文献速递妇科

抗血栓治疗相关月经过多患者的管理疗效分析

[Analysis of management efficacy in patients with heavy menstrual bleeding associated with antithrombotic therapy].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2023-01-01

回顾性分析北京大学人民医院2010年1月至2022年8月收治的22例抗血栓治疗相关月经过多患者,评价急性出血治疗与长期月经管理方法。15例放置左炔诺孕酮宫内释放系统(LNG-IUS)者长期管理后月经量、血红蛋白及生命质量均显著改善。

要点

  • 宫腔球囊填塞、吸宫术或子宫内膜去除术可用于控制抗血栓治疗相关月经过多的急性出血。
  • LNG-IUS长期管理可减少月经量、升高血红蛋白并提高生命质量。
  • 12例放置LNG-IUS满6个月者PBAC评分由365.0分降至25.0分(P<0.001)。

核心结论

  • 抗血栓治疗相关月经过多患者可行宫腔球囊填塞止血、吸宫术或子宫内膜去除术控制急性出血。
  • LNG-IUS用于长期管理可减少月经量、改善贫血并提高患者的生命质量。

研究设计与样本

  • 回顾性分析2010年1月至2022年8月北京大学人民医院收治的急性异常子宫出血且有抗血栓治疗的患者共22例,中位年龄39岁(26~46岁)。

主要发现

  • 22例中16例于本院、6例于外院急诊处理出血;本院急诊处理的16例中3例因严重出血(Hb在12 h内下降20~40 g/L)急诊行宫腔球囊填塞止血。
  • 22例中15例(包括2例严重出血患者)急诊行吸宫术或子宫内膜去除术并于术中放置LNG-IUS后出血量明显减少。
  • 22例中3例利伐沙班减量后急性出血得到控制并继续观察,2例外院予促性腺激素释放激素激动剂控制急性出血(其中1例暂予周期性输血维持治疗,另1例行子宫全切除术),2例止血后口服米非司酮暂时闭经。
  • 12例放置LNG-IUS满6个月者,放置前与放置后6个月比较:PBAC评分365.0分(272.5~460.0分)vs 25.0分(12.5~37.5分),Z=4.593,P<0.001;Hb 91.5 g/L(71.8~108.2 g/L)vs 128.5 g/L(121.2~142.5 g/L),Z=4.695,P<0.001;MMAS评分415.0分(327.5~472.5分)vs 580.0分(570.0~580.0分),Z=-3.062,P=0.002。
  • 3例利伐沙班减量患者PBAC评分下降20~35分但仍>100分,自觉生命质量较治疗前无明显变化;2例口服米非司酮暂时闭经患者MMAS评分分别较前升高220分和180分。

临床怎么用

  • 作者认为,抗血栓治疗相关月经过多患者可行宫腔球囊填塞止血、吸宫术或子宫内膜去除术控制急性出血。
  • 作者认为,LNG-IUS用于长期管理可减少月经量、改善贫血并提高患者的生命质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate different methods' efficacy of controlling acute bleeding and managing long-term menstruation in patients with heavy menstrual bleeding (HMB) associated with antithrombotic therapy. Methods: The clinical data of 22 cases with HMB associated with antithrombotic therapy admitted to Peking University People's Hospital from January 2010 to August 2022 were analyzed, aged 39 years old (26-46 years). Changes in menstrual volume, hemoglobin (Hb), and quality of life were collected after control of acute bleeding and long-term menstrual management. Menstrual volume was assessed by pictorial blood assessment chart (PBAC), and quality of life was assessed by menorrhagia multi-attribute scale (MMAS). Results: (1) Treatment of acute bleeding: of the 22 cases with HMB associated with antithrombotic therapy, 16 cases were treated in our hospital and 6 in other hospital for emergency bleeding; of the 16 cases treated in our hospital, 3 underwent emergency intrauterine Foley catheter balloon compression due to severe bleeding (Hb decreased by 20 to 40 g/L within 12 hours). Of the 22 cases with antithrombotic therapy-related HMB, 15 (including 2 cases with severe bleeding) underwent emergency aspiration or endometrial resection, and intraoperative placement of levonorgestrel-releasing intrauterine system (LNG-IUS) followed by a significant reduction in bleeding volume; 3 cases had controlled acute bleeding after rivaroxaban dose reduction and continued observation; 2 cases were given gonadotropin-releasing hormone agonists to control acute bleeding in other hospital, of which 1 case was temporarily treated with periodic blood transfusion, and the other one patient underwent total hysterectomy; and 2 cases had temporary amenorrhea with oral mifepristone after intrauterine balloon compression or oral norethindrone. (2) Long-term menstrual management: of the 22 cases with antithrombotic therapy-related HMB, 15 had LNG-IUS placement and 12 had LNG-IUS placement for 6 months, and menstrual volume was significantly reduced [PBAC scores were 365.0 (272.5-460.0) vs 25.0 (12.5-37.5), respectively; Z=4.593, P<0.001], Hb was significantly increased [91.5 g/L (71.8-108.2 g/L) vs 128.5 g/L (121.2-142.5 g/L); Z=4.695, P<0.001], and quality of life was significantly improved [MMAS scores were 415.0 (327.5-472.5) vs 580.0 (570.0-580.0), respectively; Z=-3.062, P=0.002] before placement compared with 6 months after placement. Three rivaroxaban dose reduction patients' PBAC scores decreased by 20 to 35 but remained >100, and perceived quality of life did not change significantly. Two cases with temporary amenorrhea treated with oral mifepristone felt significantly improved quality of life, and the MMAS scores increased by 220 and 180, respectively. Conclusion: Intrauterine Foley catheter balloon compression, aspiration or endometrial ablation could be used to control acute bleeding in patients with antithrombotic therapy-related HMB, and LNG-IUS for long-term management could reduce menstrual volume, increase hemoglobin, and improve the quality of life of patients. 目的: 评价抗血栓治疗相关月经过多(HMB)患者的急性出血治疗和长期月经管理的方法及疗效。 方法: 收集2010年1月至2022年8月北京大学人民医院收治的急性异常子宫出血且有抗血栓治疗的患者共22例,其中位年龄为39岁(26~46岁)。回顾性分析抗血栓治疗相关HMB患者的急性出血治疗和长期月经管理的方法及疗效,并分析长期月经管理前后月经量、血红蛋白(Hb)及生命质量的变化。月经量的评估采用月经失血图法(PBAC)进行评分,生命质量的评估采用HMB多属性生命质量量表(MMAS)进行评分。 结果: (1)急性出血的治疗:22例抗血栓治疗相关HMB患者中,16例于本院、6例于外院急诊处理出血;本院急诊处理出血的16例患者中,3例因严重出血(Hb在12 h内下降了20~40 g/L)急诊行宫腔球囊填塞止血。22例抗血栓治疗相关HMB患者中,15例(包括2例严重出血患者)急诊行吸宫术或子宫内膜去除术并于术中放置左炔诺孕酮宫内释放系统(LNG-IUS)后出血量明显减少;3例利伐沙班减量后急性出血得到控制,继续观察;2例外院予促性腺激素释放激素激动剂控制急性出血,其中1例暂予周期性输血维持治疗,另1例行子宫全切除术;2例(宫腔内球囊压迫、口服炔诺酮各1例)止血后,口服米非司酮暂时闭经。(2)长期月经管理:22例抗血栓治疗相关HMB患者中,15例放置LNG-IUS,其中12例放置满6个月,放置前与放置后6个月相比月经量明显减少[PBAC评分分别为365.0分(272.5~460.0分)、25.0分(12.5~37.5分);Z=4.593,P<0.001],Hb明显升高[分别为91.5 g/L(71.8~108.2 g/L)、128.5 g/L(121.2~142.5 g/L);Z=4.695,P<0.001],生命质量明显提高[MMAS评分分别为415.0分(327.5~472.5分)、580.0分(570.0~580.0分);Z=-3.062,P=0.002]。3例利伐沙班减量患者的PBAC评分下降了20~35分但仍>100分,自觉生命质量较治疗前无明显变化。2例口服米非司酮暂时闭经患者自觉生命质量明显提高,MMAS评分分别较前升高了220、180分。 结论: 抗血栓治疗相关HMB患者可行宫腔球囊填塞止血、吸宫术或子宫内膜去除术控制急性出血;LNG-IUS用于长期管理可减少月经量、改善贫血并提高患者的生命质量。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jiang XL, Yan X, Su HN, et al. [Analysis of management efficacy in patients with heavy menstrual bleeding associated with antithrombotic therapy]. Zhonghua Fu Chan Ke Za Zhi. 2023. PMID: 37072297. doi:10.3760/cma.j.cn112141-20221130-00725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。